Suppr超能文献

新冠疫苗的一种不寻常副作用:风湿性多肌痛的可能诱发因素

An Unusual Side Effect of the COVID-19 Vaccine: A Possible Trigger of Polymyalgia Rheumatica.

作者信息

Ahmad Anam, Baker Donica L

机构信息

Internal Medicine, St. Luke's Hospital, Chesterfield, USA.

Rheumatology, St. Luke's Hospital, Chesterfield, USA.

出版信息

Cureus. 2022 Jul 6;14(7):e26617. doi: 10.7759/cureus.26617. eCollection 2022 Jul.

Abstract

Polymyalgia rheumatica (PMR) is characterized by myalgia and severe stiffness with decreased range of motion in the shoulder and pelvic girdles. The efficacy of the BNT 162b2 Pfizer vaccine has been proven and has been well-tolerated by patients; however, some instances of PMR have been reported after the COVID-19 vaccine. We are writing a case of a new-onset PMR in a 72-year-old woman with typical findings after receiving a booster dose of the BNT 162b2 Pfizer vaccine. This case report highlights that PMR should be in the differential diagnosis of myalgias caused by the vaccine.

摘要

风湿性多肌痛(PMR)的特征是肌痛和严重僵硬,同时肩部和骨盆带的活动范围减小。辉瑞公司的BNT 162b2疫苗的疗效已得到证实,且患者耐受性良好;然而,在接种新冠疫苗后已有一些PMR病例的报告。我们撰写了一例72岁女性在接种辉瑞公司的BNT 162b2疫苗加强针后出现新发PMR且有典型表现的病例。本病例报告强调,PMR应列入疫苗所致肌痛的鉴别诊断范围。

相似文献

7
Polymyalgia Rheumatica Following COVID-19 Vaccination.接种 COVID-19 疫苗后的巨细胞动脉炎。
Intern Med. 2022 Jun 1;61(11):1775-1777. doi: 10.2169/internalmedicine.8934-21. Epub 2022 Mar 26.
9
[Polymyalgia rheumatica].[风湿性多肌痛]
Nihon Rinsho. 1999 Feb;57(2):370-3.

本文引用的文献

8
Recent advances in the diagnosis and treatment of polymyalgia rheumatica.巨细胞动脉炎的诊断和治疗新进展。
Expert Rev Clin Immunol. 2016 Oct;12(10):1037-45. doi: 10.1080/1744666X.2016.1178572. Epub 2016 May 6.
10
Polymyalgia rheumatica and giant-cell arteritis.风湿性多肌痛和巨细胞动脉炎。
N Engl J Med. 2002 Jul 25;347(4):261-71. doi: 10.1056/NEJMra011913.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验